 | • レポートコード：D0804-15026 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、125ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、細胞療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。細胞療法の種類別市場規模（自己、同種）、用途別市場規模（病院・クリニック、ASC、再生医療センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Dendreon、PHARMICELL、Novartis AG、Mesoblast、Osiris、Vericel、JCR Pharmaceuticals Co., Ltd、MEDIPOST、GlaxoSmithKline plc、NuVasive, Inc.、EUFETS GmbH、Grupo Praxis、ANTEROGEN.CO.,LTD.、Advanced Tissue、Cognate、BioNTech IMFS、Cynata、Genzyme Corporation、Pluristem、CELLECTIS ・地域別グローバル市場分析 2015年-2020年 ・細胞療法の北米市場（アメリカ、カナダ、メキシコ） ・細胞療法のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・細胞療法のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・細胞療法の南米市場（ブラジル、アルゼンチン） ・細胞療法の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：自己、同種 ・用途別分析：病院・クリニック、ASC、再生医療センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.1% in the forecast period of 2020 to 2025 and will expected to reach USD 5860.4 million by 2025, from USD 4982.7 million in 2019.
The Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cell Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cell Therapy market has been segmented into:
Autologous
Allogeneic
By Application, Cell Therapy has been segmented into:
Hospitals and clinics
ASCs
Regenerative medicine centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cell Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Cell Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cell Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Cell Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cell Therapy Market Share Analysis
Cell Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cell Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cell Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Cell Therapy are:
Dendreon
PHARMICELL
Novartis AG
Mesoblast
Osiris
Vericel
JCR Pharmaceuticals Co., Ltd
MEDIPOST
GlaxoSmithKline plc
NuVasive, Inc.
EUFETS GmbH
Grupo Praxis
ANTEROGEN.CO.,LTD.
Advanced Tissue
Cognate
BioNTech IMFS
Cynata
Genzyme Corporation
Pluristem
CELLECTIS
Table of Contents
1 Cell Therapy Market Overview
1.1 Product Overview and Scope of Cell Therapy
1.2 Classification of Cell Therapy by Type
1.2.1 Global Cell Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cell Therapy Revenue Market Share by Type in 2019
1.2.3 Autologous
1.2.4 Allogeneic
1.3 Global Cell Therapy Market by Application
1.3.1 Overview: Global Cell Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and clinics
1.3.3 ASCs
1.3.4 Regenerative medicine centers
1.4 Global Cell Therapy Market by Regions
1.4.1 Global Cell Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cell Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cell Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cell Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cell Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Dendreon
2.1.1 Dendreon Details
2.1.2 Dendreon Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Dendreon SWOT Analysis
2.1.4 Dendreon Product and Services
2.1.5 Dendreon Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 PHARMICELL
2.2.1 PHARMICELL Details
2.2.2 PHARMICELL Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 PHARMICELL SWOT Analysis
2.2.4 PHARMICELL Product and Services
2.2.5 PHARMICELL Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis AG SWOT Analysis
2.3.4 Novartis AG Product and Services
2.3.5 Novartis AG Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Mesoblast
2.4.1 Mesoblast Details
2.4.2 Mesoblast Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Mesoblast SWOT Analysis
2.4.4 Mesoblast Product and Services
2.4.5 Mesoblast Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Osiris
2.5.1 Osiris Details
2.5.2 Osiris Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Osiris SWOT Analysis
2.5.4 Osiris Product and Services
2.5.5 Osiris Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Vericel
2.6.1 Vericel Details
2.6.2 Vericel Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Vericel SWOT Analysis
2.6.4 Vericel Product and Services
2.6.5 Vericel Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 JCR Pharmaceuticals Co., Ltd
2.7.1 JCR Pharmaceuticals Co., Ltd Details
2.7.2 JCR Pharmaceuticals Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 JCR Pharmaceuticals Co., Ltd SWOT Analysis
2.7.4 JCR Pharmaceuticals Co., Ltd Product and Services
2.7.5 JCR Pharmaceuticals Co., Ltd Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 MEDIPOST
2.8.1 MEDIPOST Details
2.8.2 MEDIPOST Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 MEDIPOST SWOT Analysis
2.8.4 MEDIPOST Product and Services
2.8.5 MEDIPOST Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline plc
2.9.1 GlaxoSmithKline plc Details
2.9.2 GlaxoSmithKline plc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline plc SWOT Analysis
2.9.4 GlaxoSmithKline plc Product and Services
2.9.5 GlaxoSmithKline plc Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 NuVasive, Inc.
2.10.1 NuVasive, Inc. Details
2.10.2 NuVasive, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 NuVasive, Inc. SWOT Analysis
2.10.4 NuVasive, Inc. Product and Services
2.10.5 NuVasive, Inc. Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 EUFETS GmbH
2.11.1 EUFETS GmbH Details
2.11.2 EUFETS GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 EUFETS GmbH SWOT Analysis
2.11.4 EUFETS GmbH Product and Services
2.11.5 EUFETS GmbH Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Grupo Praxis
2.12.1 Grupo Praxis Details
2.12.2 Grupo Praxis Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Grupo Praxis SWOT Analysis
2.12.4 Grupo Praxis Product and Services
2.12.5 Grupo Praxis Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 ANTEROGEN.CO.,LTD.
2.13.1 ANTEROGEN.CO.,LTD. Details
2.13.2 ANTEROGEN.CO.,LTD. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 ANTEROGEN.CO.,LTD. SWOT Analysis
2.13.4 ANTEROGEN.CO.,LTD. Product and Services
2.13.5 ANTEROGEN.CO.,LTD. Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.14 Advanced Tissue
2.14.1 Advanced Tissue Details
2.14.2 Advanced Tissue Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Advanced Tissue SWOT Analysis
2.14.4 Advanced Tissue Product and Services
2.14.5 Advanced Tissue Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.15 Cognate
2.15.1 Cognate Details
2.15.2 Cognate Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Cognate SWOT Analysis
2.15.4 Cognate Product and Services
2.15.5 Cognate Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.16 BioNTech IMFS
2.16.1 BioNTech IMFS Details
2.16.2 BioNTech IMFS Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 BioNTech IMFS SWOT Analysis
2.16.4 BioNTech IMFS Product and Services
2.16.5 BioNTech IMFS Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.17 Cynata
2.17.1 Cynata Details
2.17.2 Cynata Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Cynata SWOT Analysis
2.17.4 Cynata Product and Services
2.17.5 Cynata Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.18 Genzyme Corporation
2.18.1 Genzyme Corporation Details
2.18.2 Genzyme Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Genzyme Corporation SWOT Analysis
2.18.4 Genzyme Corporation Product and Services
2.18.3 Genzyme Corporation Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.19 Pluristem
2.19.1 Pluristem Details
2.19.2 Pluristem Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Pluristem SWOT Analysis
2.19.4 Pluristem Product and Services
2.19.5 Pluristem Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.20 CELLECTIS
2.20.1 CELLECTIS Details
2.20.2 CELLECTIS Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 CELLECTIS SWOT Analysis
2.20.4 CELLECTIS Product and Services
2.20.5 CELLECTIS Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cell Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell Therapy Players Market Share
3.2.2 Top 10 Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cell Therapy Revenue and Market Share by Regions
4.2 North America Cell Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Cell Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cell Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Cell Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cell Therapy Revenue and Growth Rate (2015-2020)
5 North America Cell Therapy Revenue by Countries
5.1 North America Cell Therapy Revenue by Countries (2015-2020)
5.2 USA Cell Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Cell Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Cell Therapy Revenue and Growth Rate (2015-2020)
6 Europe Cell Therapy Revenue by Countries
6.1 Europe Cell Therapy Revenue by Countries (2015-2020)
6.2 Germany Cell Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Cell Therapy Revenue and Growth Rate (2015-2020)
6.4 France Cell Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Cell Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Cell Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cell Therapy Revenue by Countries
7.1 Asia-Pacific Cell Therapy Revenue by Countries (2015-2020)
7.2 China Cell Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Cell Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Cell Therapy Revenue and Growth Rate (2015-2020)
7.5 India Cell Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cell Therapy Revenue and Growth Rate (2015-2020)
8 South America Cell Therapy Revenue by Countries
8.1 South America Cell Therapy Revenue by Countries (2015-2020)
8.2 Brazil Cell Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Cell Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cell Therapy by Countries
9.1 Middle East & Africa Cell Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cell Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Cell Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Cell Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Cell Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cell Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Cell Therapy Market Forecast by Type (2019-2024)
10.3 Autologous Revenue Growth Rate (2015-2025)
10.4 Allogeneic Revenue Growth Rate (2015-2025)
11 Global Cell Therapy Market Segment by Application
11.1 Global Cell Therapy Revenue Market Share by Application (2015-2020)
11.2 Cell Therapy Market Forecast by Application (2019-2024)
11.3 Hospitals and clinics Revenue Growth (2015-2020)
11.4 ASCs Revenue Growth (2015-2020)
11.5 Regenerative medicine centers Revenue Growth (2015-2020)
12 Global Cell Therapy Market Size Forecast (2021-2025)
12.1 Global Cell Therapy Market Size Forecast (2021-2025)
12.2 Global Cell Therapy Market Forecast by Regions (2021-2025)
12.3 North America Cell Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Cell Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cell Therapy Revenue Market Forecast (2021-2025)
12.6 South America Cell Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cell Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cell Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cell Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cell Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Dendreon Corporate Information, Location and Competitors
Table 6. Dendreon Cell Therapy Major Business
Table 7. Dendreon Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 8. Dendreon SWOT Analysis
Table 9. Dendreon Cell Therapy Product and Solutions
Table 10. Dendreon Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. PHARMICELL Corporate Information, Location and Competitors
Table 12. PHARMICELL Cell Therapy Major Business
Table 13. PHARMICELL Cell Therapy Total Revenue (USD Million) (2018-2019)
Table 14. PHARMICELL SWOT Analysis
Table 15. PHARMICELL Cell Therapy Product and Solutions
Table 16. PHARMICELL Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis AG Corporate Information, Location and Competitors
Table 18. Novartis AG Cell Therapy Major Business
Table 19. Novartis AG Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 20. Novartis AG SWOT Analysis
Table 21. Novartis AG Cell Therapy Product and Solutions
Table 22. Novartis AG Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Mesoblast Corporate Information, Location and Competitors
Table 24. Mesoblast Cell Therapy Major Business
Table 25. Mesoblast Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 26. Mesoblast SWOT Analysis
Table 27. Mesoblast Cell Therapy Product and Solutions
Table 28. Mesoblast Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Osiris Corporate Information, Location and Competitors
Table 30. Osiris Cell Therapy Major Business
Table 31. Osiris Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 32. Osiris SWOT Analysis
Table 33. Osiris Cell Therapy Product and Solutions
Table 34. Osiris Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Vericel Corporate Information, Location and Competitors
Table 36. Vericel Cell Therapy Major Business
Table 37. Vericel Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 38. Vericel SWOT Analysis
Table 39. Vericel Cell Therapy Product and Solutions
Table 40. Vericel Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. JCR Pharmaceuticals Co., Ltd Corporate Information, Location and Competitors
Table 42. JCR Pharmaceuticals Co., Ltd Cell Therapy Major Business
Table 43. JCR Pharmaceuticals Co., Ltd Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 44. JCR Pharmaceuticals Co., Ltd SWOT Analysis
Table 45. JCR Pharmaceuticals Co., Ltd Cell Therapy Product and Solutions
Table 46. JCR Pharmaceuticals Co., Ltd Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. MEDIPOST Corporate Information, Location and Competitors
Table 48. MEDIPOST Cell Therapy Major Business
Table 49. MEDIPOST Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 50. MEDIPOST SWOT Analysis
Table 51. MEDIPOST Cell Therapy Product and Solutions
Table 52. MEDIPOST Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GlaxoSmithKline plc Corporate Information, Location and Competitors
Table 54. GlaxoSmithKline plc Cell Therapy Major Business
Table 55. GlaxoSmithKline plc Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 56. GlaxoSmithKline plc SWOT Analysis
Table 57. GlaxoSmithKline plc Cell Therapy Product and Solutions
Table 58. GlaxoSmithKline plc Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. NuVasive, Inc. Corporate Information, Location and Competitors
Table 60. NuVasive, Inc. Cell Therapy Major Business
Table 61. NuVasive, Inc. Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 62. NuVasive, Inc. SWOT Analysis
Table 63. NuVasive, Inc. Cell Therapy Product and Solutions
Table 64. NuVasive, Inc. Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. EUFETS GmbH Corporate Information, Location and Competitors
Table 66. EUFETS GmbH Cell Therapy Major Business
Table 67. EUFETS GmbH Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 68. EUFETS GmbH SWOT Analysis
Table 69. EUFETS GmbH Cell Therapy Product and Solutions
Table 70. EUFETS GmbH Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Grupo Praxis Corporate Information, Location and Competitors
Table 72. Grupo Praxis Cell Therapy Major Business
Table 73. Grupo Praxis Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 74. Grupo Praxis SWOT Analysis
Table 75. Grupo Praxis Cell Therapy Product and Solutions
Table 76. Grupo Praxis Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. ANTEROGEN.CO.,LTD. Corporate Information, Location and Competitors
Table 78. ANTEROGEN.CO.,LTD. Cell Therapy Major Business
Table 79. ANTEROGEN.CO.,LTD. Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 80. ANTEROGEN.CO.,LTD. SWOT Analysis
Table 81. ANTEROGEN.CO.,LTD. Cell Therapy Product and Solutions
Table 82. ANTEROGEN.CO.,LTD. Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Advanced Tissue Corporate Information, Location and Competitors
Table 84. Advanced Tissue Cell Therapy Major Business
Table 85. Advanced Tissue Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 86. Advanced Tissue SWOT Analysis
Table 87. Advanced Tissue Cell Therapy Product and Solutions
Table 88. Advanced Tissue Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Cognate Corporate Information, Location and Competitors
Table 90. Cognate Cell Therapy Major Business
Table 91. Cognate Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 92. Cognate SWOT Analysis
Table 93. Cognate Cell Therapy Product and Solutions
Table 94. Cognate Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. BioNTech IMFS Corporate Information, Location and Competitors
Table 96. BioNTech IMFS Cell Therapy Major Business
Table 97. BioNTech IMFS Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 98. BioNTech IMFS SWOT Analysis
Table 99. BioNTech IMFS Cell Therapy Product and Solutions
Table 100. BioNTech IMFS Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Cynata Corporate Information, Location and Competitors
Table 102. Cynata Cell Therapy Major Business
Table 103. Cynata Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 104. Cynata SWOT Analysis
Table 105. Cynata Cell Therapy Product and Solutions
Table 106. Cynata Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Genzyme Corporation Cell Therapy Type and Application
Table 108. Genzyme Corporation Cell Therapy Major Business
Table 109. Genzyme Corporation Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 110. Genzyme Corporation SWOT Analysis
Table 111. Genzyme Corporation Cell Therapy Product and Solutions
Table 112. Genzyme Corporation Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Pluristem Corporate Information, Location and Competitors
Table 114. Pluristem Cell Therapy Major Business
Table 115. Pluristem Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 116. Pluristem SWOT Analysis
Table 117. Pluristem Cell Therapy Product and Solutions
Table 118. Pluristem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. CELLECTIS Corporate Information, Location and Competitors
Table 120. CELLECTIS Cell Therapy Major Business
Table 121. CELLECTIS Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 122. CELLECTIS SWOT Analysis
Table 123. CELLECTIS Cell Therapy Product and Solutions
Table 124. CELLECTIS Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Global Cell Therapy Revenue (Million USD) by Players (2015-2020)
Table 126. Global Cell Therapy Revenue Share by Players (2015-2020)
Table 127. Global Cell Therapy Revenue (Million USD) by Regions (2015-2020)
Table 128. Global Cell Therapy Revenue Market Share by Regions (2015-2020)
Table 129. North America Cell Therapy Revenue by Countries (2015-2020)
Table 130. North America Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 131. Europe Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 132. Asia-Pacific Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 133. South America Cell Therapy Revenue by Countries (2015-2020)
Table 134. South America Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 135. Middle East and Africa Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 136. Middle East and Africa Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 137. Global Cell Therapy Revenue (Million USD) by Type (2015-2020)
Table 138. Global Cell Therapy Revenue Share by Type (2015-2020)
Table 139. Global Cell Therapy Revenue Forecast by Type (2021-2025)
Table 140. Global Cell Therapy Revenue by Application (2015-2020)
Table 141. Global Cell Therapy Revenue Share by Application (2015-2020)
Table 142. Global Cell Therapy Revenue Forecast by Application (2021-2025)
Table 143. Global Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cell Therapy Picture
Figure 2. Global Cell Therapy Revenue Market Share by Type in 2019
Figure 3. Autologous Picture
Figure 4. Allogeneic Picture
Figure 5. Cell Therapy Revenue Market Share by Application in 2019
Figure 6. Hospitals and clinics Picture
Figure 7. ASCs Picture
Figure 8. Regenerative medicine centers Picture
Figure 9. Global Cell Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Cell Therapy Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Cell Therapy Revenue Market Share in 2019
Figure 18. Global Top 10 Players Cell Therapy Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Cell Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Cell Therapy Revenue Market Share by Regions (2015-2020)
Figure 22. Global Cell Therapy Revenue Market Share by Regions in 2018
Figure 23. North America Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 24. Europe Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 26. South America Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 28. North America Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 29. North America Cell Therapy Revenue Market Share by Countries in 2019
Figure 30. USA Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 31. Canada Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Europe Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Cell Therapy Revenue Market Share by Countries in 2019
Figure 35. Germany Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 36. UK Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 37. France Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 38. Russia Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 39. Italy Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Cell Therapy Revenue Market Share by Countries in 2019
Figure 42. China Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 43. Japan Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 44. Korea Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 45. India Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 47. South America Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 48. South America Cell Therapy Revenue Market Share by Countries in 2019
Figure 49. Brazil Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Cell Therapy Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 54. UAE Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 57. Global Cell Therapy Revenue Share by Type (2015-2020)
Figure 58. Global Cell Therapy Revenue Share by Type in 2019
Figure 59. Global Cell Therapy Market Share Forecast by Type (2021-2025)
Figure 60. Global Autologous Revenue Growth Rate (2015-2020)
Figure 61. Global Allogeneic Revenue Growth Rate (2015-2020)
Figure 62. Global Cell Therapy Revenue Share by Application (2015-2020)
Figure 63. Global Cell Therapy Revenue Share by Application in 2019
Figure 64. Global Cell Therapy Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals and clinics Revenue Growth Rate (2015-2020)
Figure 66. Global ASCs Revenue Growth Rate (2015-2020)
Figure 67. Global Regenerative medicine centers Revenue Growth Rate (2015-2020)
Figure 68. Global Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Cell Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Cell Therapy Revenue Market Forecast (2021-2025)
Figure 72. Europe Cell Therapy Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Cell Therapy Revenue Market Forecast (2021-2025)
Figure 74. South America Cell Therapy Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Cell Therapy Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
細胞治療技術の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cell Therapy Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.8% in the forecast period of 2020 to 2025 and will expected to reach USD 12980 million by 2025, from USD 9609.3 million in 2019. The Cell Therap…- 脂肪由来幹細胞治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Adipose Derived Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 脂肪組織由来幹細胞治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Adipose Tissue-derived Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- 動物幹細胞療法の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Animal Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- T細胞急性リンパ性白血病治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global T-cell Acute Lymphoblastic Leukemia Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The…